Page last updated: 2024-08-23

epirubicin and Sarcoma, Epithelioid

epirubicin has been researched along with Sarcoma, Epithelioid in 66 studies

Research

Studies (66)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (9.09)	18.7374
1990's	21 (31.82)	18.2507
2000's	13 (19.70)	29.6817
2010's	20 (30.30)	24.3611
2020's	6 (9.09)	2.80

Authors

Authors	Studies
Jiang, X; Li, M; Ma, ST; Miao, L; Wang, YM; Zhang, HH	1
Chen, LS; Guo, X; Hou, YY; Liu, WS; Lu, WQ; Luo, RK; Wang, ZM; You, Y; Zhang, CL; Zhang, Y; Zhou, YH; Zhuang, RY	1
Chan, WT; Hou, JY; Jiang, CB; Lee, HC; Liu, HC; Liu, YC; Sheu, JC; Wu, PS; Yeh, TC; Yeung, CY	1
Alatorre-Alexander, JA; Carrasco-CaraChards, S; Cruz-Zermeño, M; de Jesús Rodríguez-Zea, I; Godina-Flores, A; Green-Renner, D; Guzmán-Casta, J; Guzmán-Huesca, J; Imaz-Olguin, V; Juarez-Vignon Whaley, JJ; Martínez-Barrera, LM; Riera-Sala, R; Rodriguez-Cid, JR; Sánchez-Domínguez, G; Sánchez-Ríos, CP; Santillán-Doherty, PJ; Seidman-Sorsby, A; Sosa-Sánchez, R	1
Jones, RL	1
Guo, X; Lu, WQ; Tong, HX; Wang, ZM; Yang, H; Zhang, SL; Zhang, Y; Zhou, YH; Zhuang, RY	1
Hua, Q; Xu, G; Zhang, T; Zhao, L	1
Du, Z; Li, X; Wang, X; Xia, Y	1
Charlson, J	1
Lu, E; Ryan, CW	1
Amesty, MV; Chenu, BG; Chocarro, G; Gámez, M; Hernández, F; Hernández, S; Ortíz, R; Sánchez, A; Santamaría, ML; Tovar, JA	1
Cao, J; Huang, XE; Liu, J; Lu, YY; Wu, XY	1
Bray, J; Polton, G	1
Adkins, DR; Luo, J; Montgomery, L; Morgensztern, D; Schenone, AD; Van Tine, BA	1
Bottelli, S; Casali, PG; Comandone, A; De Paoli, A; De Sanctis, R; Ferrari, S; Gronchi, A; Libertini, M; Lopez-Pousa, A; Martin Broto, J; Palassini, E; Palmerini, E; Picci, P; Quagliuolo, V; Sangalli, C; Verderio, P	1
Basso, U; Brunello, A; Buzzaccarini, MS; Fiduccia, P; Maruzzo, M; Rastrelli, M; Rizzato, MD; Roma, A; Rossi, CR; Scarzello, G; Zagonel, V	1
Aggarwal, R; Chen, S; Cripps, AM; Daud, A; Grabowsky, JA; Hwang, J; Jahan, T; Munster, PN; Park, J; Raha, P; Ryan, C; Thomas, S; Thurn, KT; Troung, T	1
Amadori, D; Bongiovanni, A; De Vita, A; Di Iorio, V; Foca, F; Ibrahim, T; Liverani, C; Mercatali, L; Miserocchi, G; Monti, M; Recine, F; Riva, N	1
Connell, PP; Haydon, RC; Luu, HH; MacDermed, DM; Miller, LL; Montag, AG; Peabody, TD; Simon, MA; Undevia, SD	1
Carinelli, S; Maggioni, A; Peiretti, M; Rosenberg, P; Zanagnolo, V	1
Casali, PG; Comandone, A; De Paoli, A; Dei Tos, AP; Frustaci, S; Gronchi, A; Longhi, A; Lopez-Pousa, A; Mariani, L; Martin, J; Mercuri, M; Miceli, R; Picci, P; Poveda, A; Quagliuolo, V; Stacchiotti, S; Valagussa, P; Verderio, P	1
Bergeron, C; Bouvet, N; Ellershaw, C; Jenney, ME; Kelsey, A; Martelli, H; Merks, JH; Oberlin, O; Rey, A; Sanchez de Toledo, J; Scopinaro, M; Spooner, D; Stevens, MC	1
Baldi, A; Citro, G; Fanciulli, M; Spugnini, EP	1
Casali, PG; Comandone, A; De Paoli, A; Dei Tos, AP; Ferrari, S; Ferraro, A; Fiore, M; Frustaci, S; Grignani, G; Gronchi, A; Majò, J; Martin, J; Palassini, E; Picci, P; Pizzamiglio, S; Quagliuolo, V; Stacchiotti, S; Tendero, O; Verderio, P	1
Brauchlin, A; Erne, P; Müller, A; Odermatt, Y; Toggweiler, S; Winterhalder, R; Zander, T; Zuber, M	1
Badalamenti, G; Bronte, G; Fulfaro, F; Incorvaia, L; Leto, G; Maltese, G; Provenzano, S	1
Civitelli, S; Coratti, A; Correale, P; D'Aniello, C; Francini, G; Grimaldi, L; Marsili, S; Marzocca, G; Messinese, S; Petrioli, R; Pirtoli, L; Tanzini, G	1
Baranzelli, MC; Barnouin, L; Bay, JO; Bui, NB; Chevreau, C; Cupissol, D; Eymard, JC; Lortholary, A; Mita, M; Pivot, X; Savary, J; Thyss, A	1
Bonde, CT; Kirkegaard, P; Mogensen, AM; Nielsen, K; Rasmussen, A	1
Aoe, M; Kanehiro, A; Kiura, K; Ohohara, N; Tabata, M; Tanimoto, M; Tanimoto, Y; Uchida, A; Ueoka, H	1
Oberlin, O; Orbach, D; Quintana, E; Rey, A; Sanchez de Toledo, J; Stevens, MC; Terrier-Lacombe, MJ; van Unnik, A	1
Beck, JD; Brecht, I; Kremers, A; Langer, T; Paulides, M; Stöhr, W; Treuner, J	1
Bamias, A; Bozas, G; Dimopoulos, MA; Gika, D; Kastritis, E; Markaki, S; Papadimitriou, CA; Rodolakis, A; Voulgaris, Z; Zorzou, MP	1
Beske, F; Boos, J; Dantonello, T; Gadner, H; Hallmen, E; Int-Veen, C; Kazanowska, B; Klingebiel, T; Koscielniak, E; Marky, I; Treuner, J	1
Hayden, JB; Hosenpud, JR; Hung, AY; Mansoor, A; Montag, AG; Mundt, AJ; Peabody, TD; Ryan, CW; Samuels, B; Undevia, S	1
Ferrazzi, E; Fiorentino, MV; Ganzina, F; Maraglino, G; Nicoletto, O; Pagnin, P; Vinante, O	1
Palumbo, R; Toma, S	1
Dunlop, DJ; Steward, WP; Vasey, PA	1
Buonadonna, A; Carbone, A; Crivellari, D; De Paoli, A; Foladore, S; Frustaci, S; Monfardini, S; Morassut, S; Sorio, R	1
Anagnou, J; Bokemeyer, C; Harstrick, A; Knipp, H; Köhne-Wömpner, CH; Neumann, S; Poliwoda, H; Schmoll, HJ; Schöffski, P; Wipperman, B	1
Albanese, E; Barisone, A; Canavese, G; Cantoni, E; Palumbo, R; Reggiardo, G; Rosso, R; Santi, L; Toma, S	1
Chevallier, B; Facchini, T; Fargeot, P; Leyvraz, S; Olivier, JP; Vo Van, ML	1
Bengala, C; Conte, P; Giannessi, P; Michelotti, A; Romanini, A	1
Babović, N; Filipović-Ljesković, I; Jelić, S; Kovcin, V; Kreacić, M; Milanović, N; Ristović, Z; Vlajić, M	1
Conti, F; Di Lauro, K; Ferraironi, A; Giannarelli, D; Lopez, M; Maini, CL; Paoletti, G; Sciuto, R; Vici, P	1
Dörken, B; Hohenberger, P; Reichardt, P; Tilgner, J	1
Bertero, G; Cosso, M; Neumaier, C; Palumbo, R; Pastorino, M; Raffo, P; Spadini, N; Toma, S; Valente, S; Villani, G	1
Babović, N; Gavrilović, D; Jelić, S; Kreacić, M; Matković, S; Milanović, N; Tomasević, Z	1
Apice, G; Azzarelli, A; Barbieri, E; Bonetti, M; Buonadonna, A; Comandone, A; De Paoli, A; Frustaci, S; Gherlinzoni, F; Olmi, P; Picci, P; Pignatti, G; Serraino, D; Zmerly, H	1
Cognetti, F; Gamucci, T; Nardi, M; Serrone, L; Zeuli, M	1
Cognetti, F; Nardoni, C; Pacetti, U; Papaldo, P; Serrone, L; Zeuli, M	1
Carpano, S; Di Lauro, L; Lopez, M; Vici, P	1
Bui, NB; Robert, J	1
Bokemeyer, C; Harstrick, A; Köhne-Wömpner, CH; Poliwoda, H; Schmoll, HJ; Schöffski, P	1
Kelman, AW; Kerr, DJ; Robert, J; Wade, JR; Whiting, B	1
Palumbo, R; Santi, L; Sogno, G; Toma, S; Venturino, A	1
Azzarelli, A; Bignami, P; Bonadonna, G; Casali, P; Devizzi, L; Pastorino, U; Quagliuolo, V; Santoro, A; Zucchinelli, P	1
Carpano, S; Conti, EM; Di Lauro, L; Lopez, M; Vici, P	1
Bastit, P; Chevallier, B; Fachini, T; Kerbrat, P; Montcuquet, P; Nguyen Bui, B; Vo Van, ML	1
Jelić, S; Kovcin, V; Milanović, N; Tomasević, Z; Vuletić, L	1
Hoffmann, W; Könner, J; Migeod, F; Seeber, S; Weidmann, B	1
Antila, K; Eksborg, S; Stendahl, U	1
Raymond, V; Young, CW	1
Becouarn, Y; Brunet, R; Bui, BN; Chauvergne, J; Kerbrat, P; Robert, J	1
Bastholt, L; Bramwell, V; Buesa, J; Mouridsen, HT; Mulder, JH; Pinedo, HM; Santoro, A; Somers, R; Thomas, D; van Oosterom, AT	1
Fink, U; Mair, W; Mjaaland, I; Rückle, H; Sauer, H; Wilmanns, W	1

Reviews

6 review(s) available for epirubicin and Sarcoma, Epithelioid

Article	Year
Comparison of first line chemotherapy regimens for advanced soft tissue sarcoma: a network meta-analysis. Journal of chemotherapy (Florence, Italy), 2021, Volume: 33, Issue:8 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Epirubicin; Humans; Network Meta-Analysis; Progression-Free Survival; Randomized Controlled Trials as Topic; Sarcoma; Soft Tissue Neoplasms	2021
Selection of Patients With Localized Extremity Soft Tissue Sarcoma for Treatment With Perioperative Chemotherapy. Current treatment options in oncology, 2018, 10-25, Volume: 19, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Doxorubicin; Epirubicin; Humans; Ifosfamide; Neoplasm Metastasis; Neoplasm Recurrence, Local; Sarcoma; Soft Tissue Neoplasms	2018
Cervical sarcoma botryoides and ovarian Sertoli-Leydig cell tumor: a case report and review of literature. Archives of gynecology and obstetrics, 2012, Volume: 285, Issue:3 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Female; Humans; Ifosfamide; Neoplasms, Multiple Primary; Ovarian Neoplasms; Prolactin; Sarcoma; Sertoli-Leydig Cell Tumor; Testosterone; Treatment Outcome; Uterine Cervical Neoplasms; Young Adult	2012
Preclinical models in electrochemotherapy: the role of veterinary patients. Future oncology (London, England), 2012, Volume: 8, Issue:7 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Cat Diseases; Cats; Cisplatin; Dog Diseases; Dogs; Drug Evaluation, Preclinical; Electrochemotherapy; Epirubicin; Head and Neck Neoplasms; Melanoma; Mitoxantrone; Neoplasms; Quinazolines; Sarcoma; Thiophenes	2012
Doxorubicin (or epidoxorubicin) combined with ifosfamide in the treatment of adult advanced soft tissue sarcomas. Annals of oncology : official journal of the European Society for Medical Oncology, 1992, Volume: 3 Suppl 2 Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Epirubicin; Humans; Ifosfamide; Sarcoma; Soft Tissue Neoplasms	1992
Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives. Cancer treatment reports, 1986, Volume: 70, Issue:1 Topics: Aclarubicin; Anthraquinones; Antibiotics, Antineoplastic; Breast Neoplasms; Carubicin; Cell Survival; Daunorubicin; Doxorubicin; Drug Evaluation; Epirubicin; Heart; Humans; Idarubicin; Leukemia; Menogaril; Mitoxantrone; Naphthacenes; Nogalamycin; Sarcoma; Structure-Activity Relationship	1986

Trials

29 trial(s) available for epirubicin and Sarcoma, Epithelioid

Article	Year
Anlotinib plus Epirubicin Followed by Anlotinib Maintenance as First-line Treatment for Advanced Soft-tissue Sarcoma: An Open-label, Single-arm, Phase II Trial. Clinical cancer research : an official journal of the American Association for Cancer Research, 2022, 12-15, Volume: 28, Issue:24 Topics: Adolescent; Anemia; Epirubicin; Humans; Leukopenia; Prospective Studies; Quinolines; Sarcoma; Soft Tissue Neoplasms	2022
Neoadjuvant and adjuvant chemotherapy combined with anatomical resection of feline injection-site sarcoma: results in 21 cats. Veterinary and comparative oncology, 2016, Volume: 14, Issue:2 Topics: Animals; Cat Diseases; Cats; Chemotherapy, Adjuvant; Epirubicin; Injections; Neoadjuvant Therapy; Sarcoma	2016
Feasibility of Preoperative Chemotherapy With or Without Radiation Therapy in Localized Soft Tissue Sarcomas of Limbs and Superficial Trunk in the Italian Sarcoma Group/Grupo Español de Investigación en Sarcomas Randomized Clinical Trial: Three Versus Fiv Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Nov-01, Volume: 33, Issue:31 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Extremities; Feasibility Studies; Female; Humans; Ifosfamide; Italy; Male; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy; Regression Analysis; Sarcoma; Soft Tissue Neoplasms; Spain; Wound Healing; Young Adult	2015
A phase I trial of panobinostat and epirubicin in solid tumors with a dose expansion in patients with sarcoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2016, Volume: 27, Issue:5 Topics: Adult; Aged; Chromatin; DNA Repair; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epirubicin; Female; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; Male; Maximum Tolerated Dose; Middle Aged; Panobinostat; Sarcoma; Topoisomerase II Inhibitors	2016
Short, full-dose adjuvant chemotherapy in high-risk adult soft tissue sarcomas: a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Mar-10, Volume: 30, Issue:8 Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Administration Schedule; Epirubicin; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Italy; Middle Aged; Sarcoma; Soft Tissue Neoplasms; Spain	2012
Randomized comparison of intensified six-drug versus standard three-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma and other chemotherapy-sensitive childhood soft tissue sarcomas: long-term results from the International Society of Pediatr Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Jul-10, Volume: 30, Issue:20 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Dactinomycin; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Male; Prognosis; Rhabdomyosarcoma; Sarcoma; Treatment Outcome; Vincristine	2012
Adjuvant epirubicin with or without Ifosfamide for adult soft-tissue sarcoma. American journal of clinical oncology, 2002, Volume: 25, Issue:5 Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Epirubicin; Female; Humans; Ifosfamide; Male; Middle Aged; Sarcoma; Survival Analysis	2002
Phase II trial of paclitaxel-epirubicin in patients with recurrent soft-tissue sarcoma. American journal of clinical oncology, 2002, Volume: 25, Issue:6 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Salvage Therapy; Sarcoma; Survival Analysis	2002
Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor Committee. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Jul-01, Volume: 23, Issue:19 Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Epirubicin; Etoposide; Humans; Ifosfamide; Infant; Infant, Newborn; Neoplasm Metastasis; Neoplasm Recurrence, Local; Rhabdomyosarcoma; Sarcoma; Survival Analysis; Teniposide; Vincristine	2005
Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: report of the HD CWS-96 trial. Pediatric blood & cancer, 2008, Volume: 50, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Epirubicin; Etoposide; Female; Humans; Idarubicin; Ifosfamide; Infant; Kaplan-Meier Estimate; Male; Melphalan; Sarcoma; Soft Tissue Neoplasms; Thiotepa; Treatment Outcome; Vincristine	2008
Histologic response of dose-intense chemotherapy with preoperative hypofractionated radiotherapy for patients with high-risk soft tissue sarcomas. Cancer, 2008, Volume: 112, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dose Fractionation, Radiation; Epirubicin; Female; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Staging; Preoperative Care; Risk Factors; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome	2008
Feasibility and compliance of epirubicin plus ambulatory continuous infusion ifosfamide at escalating doses in advanced soft tissue sarcomas: a phase I study. European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Feasibility Studies; Humans; Ifosfamide; Sarcoma	1995
Epirubicin and ifosfamide in advanced soft tissue sarcomas. Annals of oncology : official journal of the European Society for Medical Oncology, 1993, Volume: 4, Issue:8 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Feasibility Studies; Female; Humans; Ifosfamide; Italy; Leukopenia; Male; Middle Aged; Remission Induction; Sarcoma; Soft Tissue Neoplasms; Survival Rate	1993
Epirubicin and ifosfamide in advanced soft tissue sarcoma: a phase II study. Cancer investigation, 1993, Volume: 11, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Epirubicin; Female; Humans; Ifosfamide; Male; Middle Aged; Sarcoma; Soft Tissue Neoplasms	1993
Accelerated epirubicin-ifosfamide-dacarbazine regimen in patients with adult soft tissue sarcomas. American journal of clinical oncology, 1996, Volume: 19, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Staging; Neutropenia; Sarcoma; Treatment Outcome	1996
Randomised study of high-dose epirubicin versus high-dose epirubicin-cisplatin chemotherapy for advanced soft tissue sarcoma. European journal of cancer (Oxford, England : 1990), 1997, Volume: 33, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cross-Over Studies; Disease-Free Survival; Epirubicin; Female; Humans; Male; Middle Aged; Prospective Studies; Sarcoma; Soft Tissue Neoplasms; Survival Rate	1997
Randomized prospective clinical trial of high-dose epirubicin and dexrazoxane in patients with advanced breast cancer and soft tissue sarcomas. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:1 Topics: Adult; Aged; Antibiotics, Antineoplastic; Breast Neoplasms; Cardiovascular Agents; Drug Monitoring; Epirubicin; Female; Heart; Heart Rate; Humans; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radionuclide Imaging; Razoxane; Sarcoma; Ventricular Function, Left	1998
Dose-intensive chemotherapy with ifosfamide, epirubicin, and filgrastim for adult patients with metastatic or locally advanced soft tissue sarcoma: a phase II study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:4 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Male; Middle Aged; Recombinant Proteins; Sarcoma; Survival Rate	1998
Dose-intensive first-line chemotherapy with epirubicin and continuous infusion ifosfamide in adult patients with advanced soft tissue sarcomas: a phase II study. European journal of cancer (Oxford, England : 1990), 1999, Volume: 35, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Epirubicin; Humans; Ifosfamide; Infusions, Intravenous; Middle Aged; Neoplasm Recurrence, Local; Sarcoma; Treatment Outcome	1999
Epirubicin 150 mg/m2-cisplatin versus epirubicin 180 mg/m2-cisplatin for advanced soft tissue sarcoma. International journal of clinical pharmacology research, 1999, Volume: 19, Issue:4 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Female; Humans; Male; Middle Aged; Sarcoma; Survival Analysis; Treatment Outcome	1999
Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Mar-01, Volume: 19, Issue:5 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Disease-Free Survival; Dose-Response Relationship, Drug; Epirubicin; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Male; Mesna; Middle Aged; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome	2001
A phase II study of dose-intense ifosfamide plus epirubicin with hematopoietic growth factors for the treatment of patients with advanced soft tissue sarcomas; a novel sequential schedule. Cancer chemotherapy and pharmacology, 2001, Volume: 47, Issue:3 Topics: Adolescent; Adult; Aged; Alopecia; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Ifosfamide; Male; Middle Aged; Nausea; Sarcoma; Soft Tissue Neoplasms; Vomiting	2001
Ifosfamide and epirubicin combination in untreated sarcomas: two treatment schedules. Onkologie, 2001, Volume: 24, Issue:5 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Female; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Staging; Sarcoma; Soft Tissue Neoplasms; Survival Rate	2001
Doxorubicin (or epidoxorubicin) combined with ifosfamide in the treatment of adult advanced soft tissue sarcomas. Annals of oncology : official journal of the European Society for Medical Oncology, 1992, Volume: 3 Suppl 2 Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Epirubicin; Humans; Ifosfamide; Sarcoma; Soft Tissue Neoplasms	1992
Epirubicin and DTIC (EDIC) for advanced soft-tissue sarcomas. Oncology, 1991, Volume: 48, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Epirubicin; Female; Humans; Middle Aged; Sarcoma; Soft Tissue Neoplasms	1991
High-dose epirubicin-cisplatin chemotherapy for advanced soft tissue sarcoma. Tumori, 1990, Oct-31, Volume: 76, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Female; Humans; Male; Middle Aged; Pilot Projects; Sarcoma; Soft Tissue Neoplasms	1990
Pharmacokinetics of 4' epi-adriamycin after morning and afternoon intravenous administration. Medical oncology and tumor pharmacotherapy, 1989, Volume: 6, Issue:3 Topics: Aged; Analysis of Variance; Biological Availability; Carcinoma; Circadian Rhythm; Epirubicin; Female; Humans; Infusions, Intravenous; Middle Aged; Ovarian Neoplasms; Random Allocation; Sarcoma; Uterine Neoplasms	1989
Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC Soft Tissue and Bone Sarcoma Group. European journal of cancer & clinical oncology, 1987, Volume: 23, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Doxorubicin; Drug Evaluation; Epirubicin; Female; Hematologic Diseases; Humans; Male; Middle Aged; Random Allocation; Sarcoma; Soft Tissue Neoplasms; Time Factors	1987
[Polychemotherapy of advanced soft tissue sarcomas with 4'-epi-doxorubicin (4'-Epi-DX) and cisplatin (DDP)]. Onkologie, 1986, Volume: 9 Suppl 1 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Doxorubicin; Epirubicin; Female; Humans; Male; Middle Aged; Prognosis; Sarcoma; Soft Tissue Neoplasms	1986

Other Studies

32 other study(ies) available for epirubicin and Sarcoma, Epithelioid

Article	Year
Prediction of the therapeutic efficacy of epirubicin combined with ifosfamide in patients with lung metastases from soft tissue sarcoma based on contrast-enhanced CT radiomics features. BMC medical imaging, 2022, 07-26, Volume: 22, Issue:1 Topics: Epirubicin; Humans; Ifosfamide; Lung Neoplasms; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed	2022
Rare presentation in a rare case of pancreatic extraosseous Ewing's sarcoma: A case report. Medicine, 2022, Nov-25, Volume: 101, Issue:47 Topics: Adolescent; Cyclophosphamide; Dysuria; Epirubicin; Etoposide; Flank Pain; Humans; Ifosfamide; Male; Pancreas; Pancreatic Neoplasms; Sarcoma; Sarcoma, Ewing; Soft Tissue Neoplasms; Vincristine	2022
Epirubicin, cisplatin plus ifosfamide versus standard chemotherapeutic regimens for advanced/unresectable primary thoracic sarcomas. Journal of cancer research and clinical oncology, 2023, Volume: 149, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Humans; Ifosfamide; Prospective Studies; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms	2023
Sarcomas and old age: few options for such a large patient population. Future oncology (London, England), 2019, Volume: 15, Issue:26s Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Deoxycytidine; Doxorubicin; Epirubicin; Gemcitabine; Geriatric Assessment; Humans; Ifosfamide; Male; Prognosis; Sarcoma; Survival Rate; Trabectedin	2019
Efficacy and safety of anlotinib, a multikinase angiogenesis inhibitor, in combination with epirubicin in preclinical models of soft tissue sarcoma. Cancer medicine, 2020, Volume: 9, Issue:10 Topics: Angiogenesis Inhibitors; Animals; Antibiotics, Antineoplastic; Apoptosis; Cardiotoxicity; Cell Proliferation; Drug Therapy, Combination; Epirubicin; ErbB Receptors; Female; Heart; Histiocytoma, Malignant Fibrous; Humans; Immunohistochemistry; Indoles; Ki-67 Antigen; Mice; Mice, Nude; Microvascular Density; Myocardium; Platelet Endothelial Cell Adhesion Molecule-1; Quinolines; Sarcoma; Tumor Burden; Xenograft Model Antitumor Assays	2020
Treatment of Uterine Sarcoma with rAd-p53 (Gendicine) Followed by Chemotherapy: Clinical Study of TP53 Gene Therapy. Human gene therapy, 2018, Volume: 29, Issue:2 Topics: Adenoviridae; Adult; Bleomycin; Cisplatin; Combined Modality Therapy; Epirubicin; Female; Genetic Therapy; Humans; Liver Neoplasms; Middle Aged; Progression-Free Survival; Recombinant Proteins; Sarcoma; Tumor Suppressor Protein p53; Uterine Neoplasms	2018
ASO Author Reflections: Chemoradiation for High-Risk Soft Tissue Sarcomas. Annals of surgical oncology, 2018, Volume: 25, Issue:Suppl 3 Topics: Chemoradiotherapy; Epirubicin; Humans; Ifosfamide; Sarcoma; Soft Tissue Neoplasms	2018
Embryonal sarcoma of the liver. Pediatric surgery international, 2013, Volume: 29, Issue:12 Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Doxorubicin; Epirubicin; Female; Humans; Ifosfamide; Infant; Liver; Liver Neoplasms; Male; Retrospective Studies; Sarcoma; Survival Analysis; Treatment Outcome; Vincristine	2013
Comparison of efficacy and toxicity of first line chemotherapy with or without epirubicin for patients with advanced stage soft tissue sarcoma. Asian Pacific journal of cancer prevention : APJCP, 2013, Volume: 14, Issue:12 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Deoxycytidine; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Ifosfamide; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Paclitaxel; Prognosis; Retrospective Studies; Sarcoma; Survival Rate; Young Adult	2013
Risk-stratified patients with resectable soft tissue sarcoma benefit from epirubicin-based adjuvant chemotherapy. Cancer medicine, 2014, Volume: 3, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Disease-Free Survival; Doxorubicin; Epirubicin; Female; Humans; Ifosfamide; Male; Middle Aged; Risk Factors; Sarcoma	2014
Adjuvant chemotherapy for soft tissue sarcomas: a 10-year mono-institutional experience. Journal of cancer research and clinical oncology, 2016, Volume: 142, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Epirubicin; Female; Humans; Ifosfamide; Male; Middle Aged; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Survival Analysis; Young Adult	2016
Recombinant granulocyte colony-stimulating factor (rG-CSF) in the management of neutropenia induced by anthracyclines and ifosfamide in patients with soft tissue sarcomas (NEUSAR). Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2017, Volume: 25, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy-Induced Febrile Neutropenia; Epirubicin; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematologic Agents; Humans; Ifosfamide; Lenograstim; Male; Middle Aged; Recombinant Proteins; Retrospective Studies; Sarcoma	2017
Primary tumor necrosis predicts distant control in locally advanced soft-tissue sarcomas after preoperative concurrent chemoradiotherapy. International journal of radiation oncology, biology, physics, 2010, Mar-15, Volume: 76, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Drug Administration Schedule; Epirubicin; Extremities; Female; Humans; Ifosfamide; Male; Middle Aged; Necrosis; Radiotherapy Dosage; Radiotherapy, Adjuvant; Retrospective Studies; Sarcoma; Survival Rate; Tumor Burden; Young Adult	2010
Quality of surgery and neoadjuvant combined therapy in the ISG-GEIS trial on soft tissue sarcomas of limbs and trunk wall. Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Epirubicin; Extremities; Female; Humans; Ifosfamide; Male; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Proportional Hazards Models; Randomized Controlled Trials as Topic; Sarcoma; Soft Tissue Neoplasms; Surgical Procedures, Operative; Thoracic Neoplasms; Torso; Treatment Outcome; Young Adult	2013
The clinical value of echocardiography and acoustic cardiography to monitor patients undergoing anthracycline chemotherapy. Clinical cardiology, 2013, Volume: 36, Issue:4 Topics: Age Factors; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antibiotics, Antineoplastic; Breast Neoplasms; Coronary Artery Disease; Doxorubicin; Echocardiography; Epirubicin; Female; Follow-Up Studies; Heart Sounds; Humans; Hypertension; Lymphoma; Male; Middle Aged; Multivariate Analysis; Phonocardiography; Prospective Studies; Sarcoma; Sensitivity and Specificity; Sex Factors; Stroke Volume; Systole; Ventricular Function, Left	2013
Lenograstim in preventing chemotherapy-induced febrile neutropenia in patients with soft tissue sarcoma. Anticancer research, 2013, Volume: 33, Issue:2 Topics: Adjuvants, Immunologic; Adult; Aged; Antineoplastic Agents; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lenograstim; Male; Middle Aged; Neutropenia; Recombinant Proteins; Sarcoma; Soft Tissue Neoplasms; Young Adult	2013
[Follicular dendritic cell sarcoma]. Ugeskrift for laeger, 2005, May-02, Volume: 167, Issue:18 Topics: Abdominal Neoplasms; Adult; Antibiotics, Antineoplastic; Dendritic Cells, Follicular; Epirubicin; Humans; Liver Neoplasms; Liver Transplantation; Male; Neoplasm Recurrence, Local; Sarcoma	2005
Successful treatment of pulmonary artery sarcoma by a two-drug combination chemotherapy consisting of ifosfamide and epirubicin. Japanese journal of clinical oncology, 2005, Volume: 35, Issue:7 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Female; Humans; Ifosfamide; Prognosis; Pulmonary Artery; Sarcoma; Tomography, X-Ray Computed; Vascular Neoplasms	2005
Comparison of epirubicin and doxorubicin cardiotoxicity in children and adolescents treated within the German Cooperative Soft Tissue Sarcoma Study (CWS). Journal of cancer research and clinical oncology, 2006, Volume: 132, Issue:1 Topics: Adolescent; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathy, Restrictive; Child; Child, Preschool; Doxorubicin; Echocardiography; Epirubicin; Female; Heart; Heart Function Tests; Humans; Incidence; Male; Prospective Studies; Randomized Controlled Trials as Topic; Sarcoma; Ventricular Function, Left	2006
Anthracycline-based adjuvant chemotherapy in early-stage uterine sarcomas: long-term results of a single institution experience. European journal of gynaecological oncology, 2007, Volume: 28, Issue:2 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Neoplasm Staging; Sarcoma; Survival Analysis; Treatment Outcome; Uterine Neoplasms	2007
Phase II study of 4'epi-doxorubicin. Tumori, 1982, Oct-31, Volume: 68, Issue:5 Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Doxorubicin; Drug Evaluation; Epirubicin; Female; Heart; Humans; Male; Melanoma; Middle Aged; Neoplasms; Sarcoma	1982
Nephrogenic diabetes insipidus following high dose epirubicin chemotherapy for metastatic soft tissue sarcoma. European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A, Issue:1 Topics: Diabetes Insipidus, Nephrogenic; Epirubicin; Female; Humans; Middle Aged; Pelvic Neoplasms; Sarcoma	1995
A pilot study of rapidly alternating epirubicin/dacarbazine and ifosfamide as first-line therapy for metastatic soft-tissue sarcoma in adults. Cancer chemotherapy and pharmacology, 1993, Volume: 31 Suppl 2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Drug Administration Schedule; Epirubicin; Feasibility Studies; Female; Humans; Ifosfamide; Male; Middle Aged; Pilot Projects; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome	1993
Ifosfamide plus epirubicin at escalating doses in the treatment of locally advanced and/or metastatic sarcomas. Cancer chemotherapy and pharmacology, 1993, Volume: 31 Suppl 2 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Neoplasms; Drug Administration Schedule; Epirubicin; Female; Humans; Ifosfamide; Male; Middle Aged; Sarcoma; Soft Tissue Neoplasms; Survival Analysis; Treatment Outcome	1993
Increasing single epirubicin doses in advanced soft tissue sarcomas. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Mar-01, Volume: 20, Issue:5 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Drug Administration Schedule; Epirubicin; Female; Humans; Male; Middle Aged; Sarcoma; Soft Tissue Neoplasms; Survival Rate	2002
Pharmacokinetics and metabolism of epirubicin administered as i.v. bolus and 48-h infusion in patients with advanced soft-tissue sarcoma. Annals of oncology : official journal of the European Society for Medical Oncology, 1992, Volume: 3, Issue:8 Topics: Adolescent; Adult; Aged; Epirubicin; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Sarcoma; Soft Tissue Neoplasms; Time Factors	1992
Epirubicin/dacarbazine rapidly alternated with ifosfamide in the treatment of metastatic soft tissue sarcomas. Annals of oncology : official journal of the European Society for Medical Oncology, 1992, Volume: 3, Issue:6 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Epirubicin; Female; Humans; Ifosfamide; Male; Middle Aged; Sarcoma; Soft Tissue Neoplasms	1992
Variability in the pharmacokinetics of epirubicin: a population analysis. Cancer chemotherapy and pharmacology, 1992, Volume: 29, Issue:5 Topics: Adult; Aged; Aging; Breast Neoplasms; Chromatography, High Pressure Liquid; Epirubicin; Female; Hodgkin Disease; Humans; Linear Models; Male; Middle Aged; Models, Biological; Sarcoma; Sex Characteristics; Time Factors	1992
Epirubicin plus ifosfamide and dacarbazine (EID) in advanced soft tissue sarcomas. Annals of oncology : official journal of the European Society for Medical Oncology, 1992, Volume: 3 Suppl 2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Epirubicin; Follow-Up Studies; Humans; Ifosfamide; Sarcoma; Soft Tissue Neoplasms	1992
Phase II study of epirubicin in advanced soft tissue sarcoma. Bulletin du cancer, 1990, Volume: 77, Issue:10 Topics: Adult; Aged; Doxorubicin; Drug Evaluation; Drug Screening Assays, Antitumor; Epirubicin; Female; Humans; Male; Middle Aged; Neutropenia; Sarcoma; Soft Tissue Neoplasms	1990
Epirubicin and ifosfamide in patients with refractory breast cancer and other metastatic solid tumours. Cancer chemotherapy and pharmacology, 1990, Volume: 26 Suppl Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Resistance; Epirubicin; Female; Humans; Ifosfamide; Neoplasm Metastasis; Sarcoma	1990
[Treatment of soft tissue sarcomas in the adult with a combination of vindesine and cisplatin with doxorubicin or epirubicin: a pilot study]. Bulletin du cancer, 1987, Volume: 74, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Humans; Male; Middle Aged; Pilot Projects; Sarcoma; Soft Tissue Neoplasms; Vindesine	1987